Literature DB >> 10220236

Recognizing factitious hypoglycemia in the family practice setting.

C M Waickus1, A de Bustros, A Shakil.   

Abstract

BACKGROUND: Factitious hypoglycemia is a deliberate attempt to induce a low serum glucose level using either insulin or oral hypoglycemic agents. Sulfonylurea-induced hypoglycemia is more common than incidents of insulin abuse, and hypoglycemia caused by these oral agents is biochemically indistinguishable from insulinoma.
METHODS: We describe a case of factitious hypoglycemia resulting from insulin abuse in an adult diabetic patient, review the essentials of glucose homeostasis, and describe diagnostic tests that allow a differential diagnosis. RESULTS AND
CONCLUSION: Factitious hypoglycemia is associated with a higher incidence of suicide, depression, and personality disorders. Insulin-induced hypoglycemia can be detected by an insulin to C-peptide ratio that is greater than 1.0. In the absence of proof to the contrary, insulinoma should be considered the cause of hypoglycemia until another diagnosis is established. The generally poor prognosis for patients with factitious hypoglycemia underscores the importance of early recognition of factitious disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220236     DOI: 10.3122/jabfm.12.2.133

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  6 in total

Review 1.  Disorders of glucose metabolism-post mortem analyses in forensic cases: part I.

Authors:  Cornelius Hess; Frank Musshoff; Burkhard Madea
Journal:  Int J Legal Med       Date:  2010-09-29       Impact factor: 2.686

2.  Factitious disorder as repeated diabetic ketoacidosis: a case report.

Authors:  Nima A Alinejad; David J Oettel
Journal:  Innov Clin Neurosci       Date:  2011-02

3.  Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franco Grimaldi; Nicola Fazio; Roberto Attanasio; Andrea Frasoldati; Enrico Papini; Francesco Angelini; Roberto Baldelli; Debora Berretti; Sara Bianchetti; Giancarlo Bizzarri; Marco Caputo; Roberto Castello; Nadia Cremonini; Anna Crescenzi; Maria Vittoria Davì; Angela Valentina D'Elia; Antongiulio Faggiano; Stefano Pizzolitto; Annibale Versari; Michele Zini; Guido Rindi; Kjell Oberg
Journal:  J Endocrinol Invest       Date:  2014-07-20       Impact factor: 4.256

4.  Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies.

Authors:  North Foulon; Elisha Goonatilleke; Michael J MacCoss; Michelle A Emrick; Andrew N Hoofnagle
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-06-10

5.  Insulin as a Tool in Factitious Dysglycemia.

Authors:  Samih A Odhaib; Qussay N Almaliki; Abbas A Mansour
Journal:  Cureus       Date:  2021-04-22

6.  C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.

Authors:  Amporn Atsawarungruangkit; Jirat Chenbhanich; George Dickstein
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.